AIM ImmunoTech, Inc. (AIM)

1.195 -0.06 (-5.16%) USD  |  NYAM  |  Jan 23, 16:00
1.24 +0.04 (+3.77%) After-Hours: 20:00
More

AIM ImmunoTech Return on Invested Capital (10y Median)

Return on Invested Capital (10y Median) Chart

View Return on Invested Capital (10y Median) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (10y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (10y Median) Range, Past 5 Years

View Return on Invested Capital (10y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (10y Median) Benchmarks

View Return on Invested Capital (10y Median) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade